| Literature DB >> 34945126 |
Adrián Domínguez-Domínguez1, Ismael Martínez-Guardado2, Francisco Javier Domínguez-Muñoz3, Sabina Barrios-Fernandez4, Jesús Morenas-Martín5, Miguel Angel Garcia-Gordillo6, Jorge Carlos-Vivas1.
Abstract
Type 1 Diabetes Mellitus (T1D) is a chronic autoimmune disease characterized by the selective destruction of the beta cells of the pancreas causing an absolute deficiency of insulin for life. This pathology carries associated risks so that it is essential to measure Health-Related Quality of Life (HRQoL) in this population. The aim was to analyse associations between the level of physical activity and HRQoL in people with T1D. The sample consisted of 172 participants with T1D diagnoses, between 18 and 49 years (31.29 ± 8.17). The participants answered different questionnaires related to physical activity (IPAQ) and HRQoL (EsDQOL, ViDa1, 15D, and EQ-5D-5L). The results showed significant correlations between the level of physical activity and HRQoL. Vigorous physical activity had an impact on the HRQoL questionnaires, such as the well-being dimension (rho = 0.349; p < 0.001) of the ViDa1 questionnaire. A significant correlation between total physical activity and levels of anxiety and depression was observed: anxiety (15D) (rho = 0.328; p < 0.001) and anxiety/depression (EQ-5D-5L) (rho = 0.324; p < 0.001). The present study showed associations between higher levels of physical activity and higher HRQoL parameters in the population with T1D, which can be erected as a reason for exercise prescription in these patients.Entities:
Keywords: diabetes mellitus; fitness; health-related quality of life; physical activity
Year: 2021 PMID: 34945126 PMCID: PMC8706820 DOI: 10.3390/jcm10245829
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Participant characteristics.
| Characteristics | Total = 172 | Women = 132 | Men = 40 | |||
|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | Mean | SD | |
| Age (years) | 31.29 | 8.17 | 30.05 | 7.64 | 35.38 | 8.64 |
| Body weight (kg) | 68.84 | 14.08 | 65.53 | 12.63 | 79.75 | 13.22 |
| Height (cm) | 166.46 | 8.96 | 163.21 | 6.78 | 177.18 | 6.65 |
| BMI (kg/m2) | 24.74 | 4.08 | 24.56 | 4.28 | 25.33 | 3.31 |
| HbA1c (%) | 6.68 | 0.73 | 6.71 | 0.74 | 6.60 | 0.68 |
| T1D years (years) | 14.51 | 9.51 | 14.36 | 9.30 | 15.00 | 10.27 |
| Current Health Status (VAS) | 74.0 | 14.1 | 73.0 | 14.5 | 76.8 | 12.5 |
BMI: body mass index; HbA1c: glycosylated haemoglobin; T1D: Type 1 Diabetes Mellitus; VAS: visual analogue scale (0, “the worst possible health status” to 100, “the best possible best health status”); SD: standard deviation.
Correlations between EsDQOL and IPAQ questionnaires in Type 1 Diabetes Mellitus population (n = 172).
| Vigorous Activity | Moderate Activity | Walking | Total Activity | Days of Physical Activity | Total Activity (min/sem) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rho |
| Rho |
| Rho |
| Rho |
| Rho |
| Rho |
| |
| EsDQOL (total score) | −0.257 ** | 0.001 | −0.179 * | 0.019 | −0.065 | 0.395 | −0.217 ** | 0.004 | −0.194 * | 0.011 | −0.203 ** | 0.008 |
| Satisfaction | −0.271 ** | 0.000 | −0.144 | 0.059 | −0.097 | 0.206 | −0.220 ** | 0.004 | −0.126 | 0.099 | −0.252 ** | 0.001 |
| Impact | −0.133 | 0.082 | −0.067 | 0.384 | −0.033 | 0.670 | −0.100 | 0.194 | −0.039 | 0.608 | −0.129 | 0.093 |
| Concern | −0.198 ** | 0.009 | −0.103 | 0.177 | −0.001 | 0.987 | −0.130 | 0.089 | −0.165 * | 0.030 | −0.091 | 0.237 |
| Diabetes-related concern | −0.157 * | 0.040 | −0.149 | 0.052 | −0.129 | 0.092 | −0.221 ** | 0.004 | −0.216 ** | 0.005 | −0.178 * | 0.019 |
** Correlation is significant at 0.01 level (bilateral); * correlation is significant at 0.05 level (bilateral). ESDQOL: Spanish version of diabetes quality of life questionnaire; METs: metabolic equivalent task; Rho: Spearman correlation coefficient. IPAQ: The International Physical Activity Questionnaire.
Correlations between ViDa1 and IPAQ questionnaires in the Type 1 Diabetes Mellitus population (n = 172).
| Vigorous Activity | Moderate Activity | Walking | Total Activity | Days of Physical Activity | Total Activity (min/sem) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rho |
| Rho |
| Rho |
| Rho |
| Rho |
| Rho |
| |
| ViDa1 (total score) | 0.262 ** | 0.001 | 0.200 ** | 0.008 | 0.123 | 0.107 | 0.239 ** | 0.002 | 0.161 * | 0.035 | 0.239 ** | 0.002 |
| Interference with life | −0.091 | 0.233 | −0.156 * | 0.040 | −0.037 | 0.632 | −0.064 | 0.404 | 0.018 | 0.814 | −0.153 * | 0.045 |
| Self-care | 0.215 ** | 0.005 | 0.102 | 0.181 | 0.211 ** | 0.005 | 0.239 ** | 0.002 | 0.090 | 0.239 | 0.216 ** | 0.004 |
| Welfare | 0.349 ** | 0.000 | 0.296 ** | 0.000 | 0.084 | 0.273 | 0.305 ** | 0.000 | 0.246 ** | 0.001 | 0.286 ** | 0.000 |
| Concern for disease | −0.106 | 0.167 | −0.027 | 0.730 | −0.008 | 0.916 | −0.073 | 0.341 | −0.118 | 0.124 | −0.072 | 0.349 |
** Correlation is significant at 0.01 level (bilateral); * correlation is significant at 0.05 level (bilateral). ViDa1: health-related quality of life questionnaire for Type-1 Diabetes; METs: metabolic equivalent task; Rho: Spearman correlation coefficient.
Correlations between 15D and IPAQ questionnaires in the Type 1 Diabetes Mellitus population (n = 172).
| Vigorous Activity | Moderate Activity | Walking | Total Activity | Days of Physical Activity | Total Activity (min/sem) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rho |
| Rho |
| Rho |
| Rho |
| Rho |
| Rho |
| |
| 15D (total score) | −0.215 ** | 0.005 | −0.217 ** | 0.004 | −0.094 | 0.221 | −0.196 * | 0.010 | −0.126 | 0.099 | −0.288 ** | <0.001 |
| Mobility | 0.047 | 0.542 | −0.016 | 0.834 | −0.173 * | 0.024 | −0.034 | 0.656 | −0.115 | 0.134 | −0.031 | 0.688 |
| Vision | −0.044 | 0.571 | −0.088 | 0.250 | −0.245 ** | 0.001 | −0.187 * | 0.014 | −0.185 * | 0.015 | −0.227 ** | 0.003 |
| Hearing | −0.135 | 0.077 | −0.114 | 0.138 | −0.115 | 0.135 | −0.126 | 0.098 | −0.153 * | 0.044 | −0.142 | 0.063 |
| Breathing | −0.166 * | 0.030 | −0.115 | 0.134 | −0.036 | 0.644 | −0.114 | 0.135 | −0.117 | 0.127 | −0.128 | 0.095 |
| Sleep | −0.112 | 0.144 | −0.112 | 0.145 | −0.020 | 0.799 | −0.101 | 0.188 | −0.086 | 0.261 | −0.149 | 0.052 |
| Eating | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Speech | 0.023 | 0.767 | −0.038 | 0.621 | −0.075 | 0.326 | 0.046 | 0.551 | 0.080 | 0.297 | −0.014 | 0.852 |
| Elimination | −0.121 | 0.113 | −0.109 | 0.154 | −0.023 | 0.765 | −0.087 | 0.255 | −0.073 | 0.343 | −0.039 | 0.610 |
| Habitual activities | −0.085 | 0.267 | −0.002 | 0.982 | −0.136 | 0.075 | −0.127 | 0.098 | −0.166 * | 0.029 | −0.105 | 0.172 |
| Mental function | −0.035 | 0.645 | −0.166 * | 0.030 | −0.041 | 0.590 | −0.082 | 0.284 | −0.062 | 0.417 | −0.116 | 0.131 |
| Discomfort and symptoms | −0.002 | 0.984 | 0.017 | 0.823 | −0.093 | 0.225 | −0.051 | 0.507 | 0.051 | 0.508 | −0.126 | 0.102 |
| Depression | −0.264 ** | <0.001 | −0.213 ** | 0.005 | −0.058 | 0.452 | −0.202 ** | 0.008 | −0.106 | 0.166 | −0.287 ** | <0.001 |
| Anxiety | −0.170 * | 0.025 | −0.188 * | 0.014 | −0.100 | 0.192 | −0.174 * | 0.022 | −0.011 | 0.883 | −0.328 ** | <0.001 |
| Vitality | −0.194 * | 0.011 | −0.222 ** | 0.003 | −0.100 | 0.193 | −0.210 ** | 0.006 | −0.174 * | 0.023 | −0.254 ** | 0.001 |
| Sexual activity | −0.100 | 0.192 | −0.092 | 0.230 | −0.011 | 0.882 | −0.117 | 0.126 | −0.099 | 0.199 | −0.158 * | 0.039 |
** Correlation is significant at 0.01 level (bilateral); * correlation is significant at 0.05 level (bilateral); 15D: 15-D questionnaire for health-related quality of life; N/A: not applicable; METs: metabolic equivalent task; Rho: Spearman correlation coefficient.
Correlations between EQ-5D-5L and IPAQ questionnaires in the Type 1 Diabetes Mellitus population (n = 172).
| Vigorous Activity | Moderate Activity | Walking | Total Activity | Days of Physical Activity | Total Activity (min/sem) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rho |
| Rho |
| Rho |
| Rho |
| Rho |
| Rho |
| |
| EQ-5D-5L (total score) | 0.157 * | 0.040 | 0.223 ** | 0.003 | 0.151 * | 0.049 | 0.189 * | 0.013 | 0.201 ** | 0.008 | 0.244 ** | 0.001 |
| Mobility | 0.032 | 0.674 | −0.066 | 0.391 | −0.073 | 0.339 | 0.003 | 0.967 | −0.038 | 0.623 | 0.027 | 0.722 |
| Personal care | −0.044 | 0.567 | 0.002 | 0.980 | −0.107 | 0.164 | −0.100 | 0.193 | −0.078 | 0.311 | −0.003 | 0.972 |
| Daily activities | −0.081 | 0.290 | −0.066 | 0.390 | −0.098 | 0.202 | −0.131 | 0.087 | −0.140 | 0.067 | −0.113 | 0.139 |
| Pain/discomfort | −0.063 | 0.410 | −0.073 | 0.344 | −0.120 | 0.118 | −0.095 | 0.216 | −0.171 * | 0.025 | −0.075 | 0.329 |
| Anxiety/depression | −0.180 * | 0.018 | −0.239 ** | 0.002 | −0.105 | 0.171 | −0.193 * | 0.011 | −0.103 | 0.179 | −0.324 ** | <0.001 |
| Health status (VAS) | 0.180 * | 0.019 | 0.133 | 0.083 | 0.173 * | 0.024 | 0.198 ** | 0.010 | 0.201 ** | 0.009 | 0.235 ** | 0.002 |
** Correlation is significant at 0.01 level (bilateral); * correlation is significant at 0.05 level (bilateral). EQ-5D-5L: Euroqol 5-dimensions questionnaire; VAS: visual analogue scale; METs: metabolic equivalent task; Rho: Spearman correlation coefficient.